Beyond Causality: Additional Benefits of Randomized Controlled Trials for Improving Health Care Delivery
Authors:
- 20 July 2021
- journal article
- research article
- Published by Wiley in The Milbank Quarterly
- Vol. 99 (4) , 864-881
Abstract
Policy Points: Policymakers at federal and state agencies, health systems, payers, and providers need rigorous evidence for strategies to improve health care delivery and population health. This is all the more urgent now, during the COVID‐19 pandemic and its aftermath, especially among low‐income communities and communities of color. Randomized controlled trials (RCTs) are known for their ability to produce credible causal impact estimates, which is why they are used to evaluate the safety and efficacy of drugs and, increasingly, to evaluate health care delivery and policy. But RCTs provide other benefits, allowing policymakers and researchers to: 1) design studies to answer the question they want to answer, 2) test theory and mechanisms to help enrich understanding beyond the results of a single study, 3) examine potentially subtle, indirect effects of a program or policy, and 4) collaborate closely to generate policy‐relevant findings. Illustrating each of these points with examples of recent RCTs in health care, we demonstrate how policymakers can utilize RCTs to solve pressing challenges.Keywords
This publication has 26 references indexed in Scilit:
- Spillover effects in epidemiology: parameters, study designs and methodological considerationsInternational Journal of Epidemiology, 2017
- The Emergence of the Randomized, Controlled TrialNew England Journal of Medicine, 2016
- Randomize evaluations to improve health care deliveryScience, 2015
- Regression Discontinuity Designs in EpidemiologyEpidemiology, 2014
- Selection in Insurance Markets: Theory and Empirics in PicturesJournal of Economic Perspectives, 2011
- Improving immunisation coverage in rural India: clustered randomised controlled evaluation of immunisation campaigns with and without incentivesBMJ, 2010
- The Credibility Revolution in Empirical Economics: How Better Research Design is Taking the Con out of EconometricsJournal of Economic Perspectives, 2010
- Race, Gender, and Partnership in the Patient-Physician RelationshipJAMA, 1999
- Comprehensive Discharge Planning and Home Follow-up of Hospitalized EldersJAMA, 1999
- The Clinical TrialNew England Journal of Medicine, 1952